Bliss GVS Pharma was incorporated in 1984 and today with five manufacturing units and has a presence in more than 60 countries its majority of revenues come from export. Bliss GVS primarily develops, manufactures, and markets products across various therapeutic categories, including Antifungal, Contraceptive, Anti-haemorrhoidal, Antispasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, and several others.
Invest Yadnya is a company that educates and simplifies the concepts of personal finance for each individual. We have amalgamated technology with financial planning expertise to help an individual meet their financial objectives. We invest time, money, and knowledge to build financial literacy in India.
We offer various products and services, including Personalized Financial Planning, Stock Market Analysis with eBook Subscriptions, Simplest Income Tax Information Bank, Comprehensive Mutual Fund Reviews, and Do-It-Yourself Financial Planning.
Invest Yadnya should be a choice because it offers unbiased and transparent stock analysis reports. Our work is knowledge-based and has specific proprietary methodologies and a stock research framework. We continuously keep updating our data and have the latest information available.
We help our clients do extensive research on 950+ companies, including Bliss GVS Pharma stock fundamental analysis. You can find the latest Bliss GVS Pharma share price on Invest Yadnya. We also provide our clients with the Balance Sheet of Bliss GVS Pharma. It helps the clients understand the financial position of the company before making any investment decisions. The Bliss GVS Pharma stock analysis helps the investors identify the intrinsic worth of the security. The profit and loss statement of Bliss GVS Pharma provides a summary of how the business incurs revenues and expenses. We give our clients a detailed analysis of the Bliss GVS Pharma results as well.
A comparative analysis of the Pharmaceuticals & Drugs Sector is available on the website. It helps to analyze the company's competitive position and its operating results over a specific period. It gives an investor a sense of whether the company is growing, stable, or deteriorating. This offers investors clarity about which stock they should invest in.
Bliss GVS Pharma’s performance analysis gives the clients a better understanding of the company’s EPS, Debt-Equity Ratio, etc. It helps clients take the first step in choosing which companies to invest in. It includes a valuation analysis of Bliss GVS Pharma stock price. The Bliss GVS Pharma annual report and Bliss GVS Pharma research report helps in fundamental and technical analysis of Bliss GVS Pharma. The economic analysis of Bliss GVS Pharma's overall benefits in allocating equity in the Portfolio of an investor to add to the portfolio’s favorable returns.
To find the Bliss GVS Pharma performance analysis & Bliss GVS Pharma fundamental analysis 2020; the latest updates, subscribe to our Equity Research and Stock Fundamental Analysis Tool, Stock-O-Meter.
Our website has information about 112 other Pharmaceuticals & Drugs Sector companies that give insight into its financials. Companies include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Divis Laboratories, Cipla, Biocon, Aurobindo Pharma, Lupin, Torrent Pharmaceuticals, Cadila Healthcare, Abbott India, Alkem Laboratories, Piramal Enterprises, GlaxoSmithKline Pharmaceuticals, Ipca Laboratories, Pfizer.